1. Home
  2. GEL vs NTLA Comparison

GEL vs NTLA Comparison

Compare GEL & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genesis Energy L.P.

GEL

Genesis Energy L.P.

N/A

Current Price

$13.60

Market Cap

1.9B

Sector

Energy

ML Signal

N/A

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

N/A

Current Price

$12.19

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GEL
NTLA
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
GEL
NTLA
Price
$13.60
$12.19
Analyst Decision
Strong Buy
Buy
Analyst Count
3
19
Target Price
$18.33
★ $24.00
AVG Volume (30 Days)
257.2K
★ 3.5M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 5.81%
N/A
EPS Growth
N/A
★ 27.43
EPS
★ 0.21
N/A
Revenue
★ $2,912,770,000.00
$67,671,000.00
Revenue This Year
$9.79
N/A
Revenue Next Year
N/A
$143.36
P/E Ratio
$65.86
★ N/A
Revenue Growth
★ 43.60
16.92
52 Week Low
$13.75
$7.95
52 Week High
$18.64
$28.24

Technical Indicators

Market Signals
Indicator
GEL
NTLA
Relative Strength Index (RSI) 25.30 50.89
Support Level N/A $11.51
Resistance Level $15.28 $12.97
Average True Range (ATR) 0.40 0.61
MACD -0.17 0.01
Stochastic Oscillator 0.11 58.32

Price Performance

Historical Comparison
GEL
NTLA

About GEL Genesis Energy L.P.

Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: